We are live on
!
Find out more
MIM
Meridiem Investment Management Portfolio holdings
AUM
$3.92B
1-Year Est. Return
1.64%
This Fund
S&P 500
This Quarter
Est. Return
+13.2%
1 Year Est. Return
-1.64%
3 Year Est. Return
+34.98%
5 Year Est. Return
+53.7%
10 Year Est. Return
–
AUM
$1.91B
AUM Growth
–
Cap. Flow
+$1.82B
Cap. Flow
% of AUM
95.4%
Top 10 Holdings %
Top 10 Hldgs %
69%
Holding
97
New
97
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$170M |
| 2 |
Microsoft
MSFT
|
+$160M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$158M |
| 4 |
Labcorp
LH
|
+$150M |
| 5 |
CERN
Cerner Corp
CERN
|
+$134M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.98% |
| 2 | Technology | 23.41% |
| 3 | Consumer Discretionary | 14.76% |
| 4 | Financials | 13.79% |
| 5 | Communication Services | 5.95% |
Similar funds
SCM
AA
BCP
AS
MSI
FLSM
LWCA
GAMH
Meridiem Investment Management's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Meridiem Investment Management, which disclosed 97 positions worth $1.91B. Its ten largest holdings account for 69% of the portfolio.
Its largest position is UnitedHealth: 508,529 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, followed by Technology and Consumer Discretionary.
- Meridiem Investment Management's largest Q4 2020 buy was UnitedHealth: 508,529 shares worth $178M.
- Meridiem Investment Management's ten largest holdings make up 69% of its $1.91B portfolio in Q4 2020.
- Meridiem Investment Management disclosed 97 positions in Q4 2020, its first 13F filing on record.
Based on Meridiem Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.